Open Access[Corrigendum] lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma
Author(s) -
Hideharu Yamada,
Masanobu Takahashi,
Munenori Watanuki,
Mika Watanabe,
Sakura Hiraide,
Ken Saijo,
Keigo Komine,
Chikashi Ishioka
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12959
Subject(s) - pazopanib , molecular medicine , library science , section (typography) , cancer , medicine , oncology , family medicine , cell cycle , computer science , sunitinib , operating system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom